Peter Lynch fit · Growth at a reasonable price (GARP)
Is Amphastar Pharmaceuticals, Inc. (AMPH) a Peter Lynch Stock?
Strong GARP candidate — growth at a reasonable price.
75/100
BLikely Lynch stock
5/6 criteria passed
Peter Lynch's Criteria, Applied to AMPH
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key181.1%
Revenue CAGR ≥ 10%
17.4%
Net margin > 0
15.4%
How AMPH Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.19B
P/E (TTM)
7.9x
ROIC (TTM)
12.28%
Gross margin
49.36%
Frequently Asked Questions
What is AMPH's Peter Lynch fit score?
AMPH scores 75/100 on our Peter Lynch fit engine — grade B. Strong GARP candidate — growth at a reasonable price.
Does Peter Lynch actually own AMPH?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AMPH.
How often is this score updated?
AMPH's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends AMPH.